BD to separate Biosciences and Diagnostic Solutions Business
BD's board approves separation plan to enhance strategic focus and growth-oriented investments and capital allocation for both BD and the separated business
BD's board approves separation plan to enhance strategic focus and growth-oriented investments and capital allocation for both BD and the separated business
See how high-resolution multiplex immunofluorescence imaging can elucidate the important role the immune system plays in health, disease, and drug development
Discover how the Resolvex A200 streamlines solid phase extraction (SPE) for proteomics with precise positive pressure technology, high-throughput automation, and reproducible results
Explore high-sensitivity troponin, antibiotic stewardship, mass spec, and more innovations and tools shaping the future of clinical labs
Discover how FT-IR is enabling fast identification of potentially harmful food fraud
Labtools.AI exhibited its open-source ELN/LIMS integration API at SLAS2025, San Diego, California
Both companies serve end users, sales partners, and original equipment manufacturer (OEM) customers